We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REAL:NASDAQThe RealReal, Inc. Analysis

Data as of 2026-07-14 - not real-time

$10.68

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The RealReal trades at $10.68, far above its DCF‑derived fair value of roughly $1.70, implying a valuation gap of over 500 % and an upside/downside metric that suggests the market is still pricing in significant upside. Technical signals are mixed: the 20‑day SMA (≈$11.55) sits above the current price, the 50‑day SMA (≈$10.64) is just below, RSI is neutral at 46, and the MACD histogram is negative, indicating bearish momentum, while volume is on a decreasing trend. Risk factors are pronounced – 30‑day volatility exceeds 60 %, beta is near 2.8, and the stock’s liquidity is weakening, all of which heighten short‑term uncertainty.
Fundamentally, the company posted 18.5 % revenue growth and boasts a sizable member base of over 40 million, yet it remains unprofitable with negative operating and net margins, a negative book value per share, and a high debt load relative to cash. Forward earnings estimates are modestly positive, but the forward PE of ~48 and a price‑to‑sales multiple of 1.78 suggest the market is betting on a turnaround that has yet to materialize. Given the overvaluation, weak profitability, and elevated risk profile, a cautious stance is warranted.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below 20‑day SMA and bearish MACD histogram
  • High beta and 30‑day volatility above 60 %
  • Decreasing volume trend indicating waning buying pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 18.5 % but continued negative margins
  • Large member base providing upside potential if monetized
  • Elevated debt relative to cash and negative book value

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term secular trend toward sustainable luxury resale
  • Uncertain path to profitability and cash‑flow generation
  • Valuation still far above DCF fair value, limiting upside upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth18.50%
Profit Margin-9.03%
P/E Ratio47.6
ROA-2.15%
P/B Ratio-3.6
Op. Cash Flow$48.7M
Free Cash Flow$19.6M

Technical Analysis

TrendNeutral
RSI45.8
Support$9.77
Resistance$13.26
MA 20$11.55
MA 50$10.64
MA 200$12.04
MACDBearish
VolumeDecreasing
Fear & Greed Index90.18

Valuation

Fair Value$1.71
Target Price$17.25
Upside/Downside61.52%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.79
Volatility63.26%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.